Viewing Study NCT04632433


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2026-01-29 @ 11:18 PM
Study NCT ID: NCT04632433
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-13
First Post: 2020-11-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma
Sponsor: Fondazione Melanoma Onlus
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module